Creative Brands Expands Portfolio with The Gift Wrap Company Acquisition Creative Brands announces the acquisition of The Gift Wrap Company, the oldest U.S. gift wrapping brand since 1903, enhancing its product portfolio.

Creative Brands Expands Portfolio with The Gift Wrap Company Acquisition #USA #Phoenix #CBC_Group #Creative_Brands #Gift_Wrap_Company

SOLVEAT and CBC Forge New Path in Botanical-Infused Beverage Development FoodTech startup SOLVEAT has joined forces with CBC Group to create innovative functional soft drinks leveraging botanical ingredients, targeting wellness.

SOLVEAT and CBC Forge New Path in Botanical-Infused Beverage Development #Israel #Tel_Aviv #CBC_Group #Functional_Drinks #SOLVEAT

Brevel and CBC Group Partner to Innovate Microalgae-Based Products for Health-Conscious Consumers Brevel, a microalgae innovator, teams up with CBC Group to develop functional drinks and dairy alternatives. This collaboration emphasizes sustainability and nutrition.

Brevel and CBC Group Partner to Innovate Microalgae-Based Products for Health-Conscious Consumers #Israel #CBC_Group #Brevel #Microalgae #Kiryat_Gat

R-Bridge Healthcare Fund Provides $50M Financing for Motiva Expansion in Asia CBC Group's R-Bridge Healthcare Fund announces $50 million financing to support Human Investments Ltd. in expanding Motiva devices in Asia.

R-Bridge Healthcare Fund Provides $50M Financing for Motiva Expansion in Asia #Singapore #CBC_Group #R-Bridge #Motiva

R-Bridge Healthcare Fund Secures $50 Million for Motiva® Expansion in Asia R-Bridge Healthcare Fund has announced a $50 million financing deal for Human Investments Ltd. to enhance the market presence of Motiva® devices across Asia, especially in China and Korea.

R-Bridge Healthcare Fund Secures $50 Million for Motiva® Expansion in Asia #Singapore #CBC_Group #Motiva® #R-Bridge

CBC Group Acquires UCB's Mature Neuroscience Portfolio in China to Enhance Patient Care CBC Group, Asia's premier healthcare investment firm, has acquired UCB's mature neurology and allergy product portfolio to elevate patient outcomes in China.

CBC Group Acquires UCB's Mature Neuroscience Portfolio in China to Enhance Patient Care #Singapore #UCB #CBC_Group #NeuroGen_Pharma

CBC Group's Strategic Acquisition of UCB's Neurology and Allergy Portfolio Fuels Growth in China CBC Group has successfully acquired UCB's neurology and allergy portfolio in China, creating NeuroGen Pharma, which aims to enhance patient outcomes in the region.

CBC Group's Strategic Acquisition of UCB's Neurology and Allergy Portfolio Fuels Growth in China #Singapore #UCB #CBC_Group #Mubadala